Wednesday
May 7, 2025
7:30 AM ET
Cognition Therapeutics Reports Financial Results for the First Quarter 2025 and Provides Business Update
Tuesday
March 25, 2025
7:30 AM ET
Cognition Therapeutics to Report Biomarker Results from Phase 2 SHINE Study in Mild-to-Moderate Alzheimer’s Disease in Podium Presentation at AD/PD 2025
Thursday
March 20, 2025
7:00 AM ET
Cognition Therapeutics Reports Year End 2024 Financial Results and Provides Business Update
Thursday
March 13, 2025
4:05 PM ET
Cognition Therapeutics to Report Fourth Quarter and Full Year 2024 Results